Show simple item record

dc.contributor.authorHirlekar, Geir
dc.date.accessioned2020-05-07T10:29:22Z
dc.date.available2020-05-07T10:29:22Z
dc.date.issued2020-05-07
dc.identifier.isbn978-91-7833-752-1 (TRYCK)
dc.identifier.isbn978-91-7833-753-8 (PDF)
dc.identifier.urihttp://hdl.handle.net/2077/63238
dc.description.abstractBackground and aim: More data is required on survival and neurological outcome after in-hospital cardiac arrest (IHCA) in the elderly. The influence of comorbidity is often neglected in cardiac arrest research, particularly after out-of-hospital cardiac arrest (OHCA). The treatment strategy of non-STEMI Acute Coronary Syndrome (NSTE-ACS) in the very elderly is debatable. Thus, the aim of this thesis was to determine the following aspects: 1) The 30-day survival of elderly patients after IHCA. 2) The impact of comorbidity on 30-day survival after OHCA. 3) Whether comorbidity impacts the effect of bystander cardio-pulmonary resuscitation (CPR) on 30-day survival after OHCA. 4) The impact between two treatment strategies in the very elderly with NSTE-ACS. Methods: Data from the Swedish Registry of Cardiopulmonary Resuscitation (SRCR) was used for analysis; IHCA (I) and OHCA (II-III). Data from the National Patient Registry (NPR) was merged with the SRCR (II-III). Study IV was a randomized controlled trial in which patients aged ≥80 years with NSTE-ACS were randomized to an invasive strategy or a conservative strategy. Results: In Study I, we found that 30-day survival decreased among the elderly with advancing age; however, among survivors, no significant association was found between age and a favourable neurological outcome. In Study II, we found that with increasing comorbidity, the likelihood of a 30-day survival after OHCA decreased. In Study III, we showed that comorbidity had no marked influence on the association between bystander CPR and 30-day survival after OHCA and that there was still a strong association between bystander CPR and 30-day survival even when adjusting for comorbidity. In Study IV, we showed that at the 12-month follow up, there was no statistically significant difference between the invasive strategy group compared to the conservative strategy group in major adverse cardiac and cerebrovascular events (MACCE) in the very elderly with NSTE-ACS. Conclusion: A decrease in survival among the elderly with advancing age but most elderly survivors from IHCA had a favourable neurological outcome. Increasing comorbidity was associated with a decreased chance of 30-day survival, but the degree of comorbidity did not affect the association of bystander CPR with 30-day survival after OHCA. No significant difference was found between the invasive and the conservative strategy group in terms of MACCE in the very elderly with NSTE-ACS at the 12-month follow-up.sv
dc.language.isoengsv
dc.relation.haspartI. Hirlekar G, Karlsson T, Aune S, Ravn-Fischer A, Albertsson P, Herlitz J, Libungan B. Survival and neurological outcome in the elderly after in-hospital cardiac arrest. Resuscitation. 2017. Sep;118:101-106. ::doi::10.1016/j.resuscitation.2017.07.013sv
dc.relation.haspartII. Hirlekar G, Jonsson M, Karlsson T, Hollenberg J, Albertsson P, Herlitz J. Comorbidity in out-of-hospital cardiac arrest. Resuscitation. 2018. Dec;133:118-123. ::doi::10.1016/j.resuscitation.2018.10.006sv
dc.relation.haspartIII. Hirlekar G, Jonsson M, Karlsson T, Bäck M, Raswhani A, Hollen-berg J, Albertsson P, Herlitz J. Comorbidity and bystander cardio-pulmonary resuscitation in out-of-hospital cardiac arrest. (E-pub 2020 Jan 23). ::doi::10.1136/heartjnl-2019-315954sv
dc.relation.haspartV. Hirlekar G, Libungan B, Karlsson T, Bäck M, Herlitz J, Albertsson P. Percu-taneous coronary intervention in the very elderly with NSTE-ACS: the randomized 80+ study. Submitted.sv
dc.subjectCardiac arrestsv
dc.subjectElderlysv
dc.subjectComorbiditysv
dc.subjectNSTE-ACSsv
dc.titleCardiac arrest with emphasis on comorbidity and choice of treatment in acute coronary syndrome in the elderlysv
dc.typetexteng
dc.type.svepDoctoral thesiseng
dc.gup.mailgeir.hirlekar@vgregion.sesv
dc.type.degreeDoctor of Philosophy (Medicine)sv
dc.gup.originUniversity of Gothenburg. Sahlgrenska Academysv
dc.gup.departmentInstitute of Medicine. Department of Molecular and Clinical Medicinesv
dc.gup.defenceplaceTorsdagen den 28 maj 2020, kl 9.00, Hjärtats Aula, Sahlgrenska Universitetssjukhuset/Sahlgrenska, Vita stråket 12, Göteborg länk: 11411007.vmr@video.vgregion.sesv
dc.gup.defencedate2020-05-28
dc.gup.dissdb-fakultetSA


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record